Moreover, the eradication of LCAR-M23 is MSLN density dependent, translating into strong cytotoxicity to tumour cells with high expression levels of MSLN and weak or no cytotoxicity to cells with low expression levels of MSLN. The gene discussed is MSLN; the disease is neoplasm.